ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 223 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2021. The put-call ratio across all filers is 2.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,913 | +30.9% | 10,724 | +25.5% | 0.01% | +50.0% |
| Q2 2023 | $107,680 | -3.4% | 8,546 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $111,525 | -29.3% | 8,546 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $157,674 | +21.3% | 8,546 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $130,000 | +3.2% | 8,546 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $126,000 | -41.1% | 8,546 | -10.1% | 0.01% | -37.5% |
| Q1 2022 | $214,000 | +22.3% | 9,502 | 0.0% | 0.01% | +33.3% |
| Q4 2021 | $175,000 | +37.8% | 9,502 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $127,000 | -37.4% | 9,502 | -13.4% | 0.01% | -28.6% |
| Q2 2021 | $203,000 | +2.5% | 10,974 | -16.7% | 0.01% | -12.5% |
| Q1 2021 | $198,000 | +4.2% | 13,170 | 0.0% | 0.01% | -11.1% |
| Q4 2020 | $190,000 | +68.1% | 13,170 | -5.3% | 0.01% | +80.0% |
| Q3 2020 | $113,000 | +20.2% | 13,910 | 0.0% | 0.01% | +25.0% |
| Q2 2020 | $94,000 | -77.6% | 13,910 | -76.6% | 0.00% | -83.3% |
| Q1 2020 | $419,000 | -28.3% | 59,450 | 0.0% | 0.02% | -7.7% |
| Q4 2019 | $584,000 | -12.8% | 59,450 | -2.6% | 0.03% | -16.1% |
| Q3 2019 | $670,000 | -8.8% | 61,034 | -3.5% | 0.03% | -6.1% |
| Q2 2019 | $735,000 | +18.5% | 63,234 | -2.6% | 0.03% | +13.8% |
| Q1 2019 | $620,000 | -3.1% | 64,943 | -2.2% | 0.03% | -17.1% |
| Q4 2018 | $640,000 | -32.3% | 66,405 | 0.0% | 0.04% | -20.5% |
| Q3 2018 | $946,000 | +15.9% | 66,405 | -2.4% | 0.04% | +12.8% |
| Q2 2018 | $816,000 | -4.4% | 68,023 | -1.6% | 0.04% | -4.9% |
| Q1 2018 | $854,000 | -15.1% | 69,163 | 0.0% | 0.04% | -10.9% |
| Q4 2017 | $1,006,000 | +10.8% | 69,163 | 0.0% | 0.05% | +7.0% |
| Q3 2017 | $908,000 | +2.8% | 69,163 | 0.0% | 0.04% | 0.0% |
| Q2 2017 | $883,000 | +30.8% | 69,163 | +30.0% | 0.04% | +30.3% |
| Q1 2017 | $675,000 | +15.8% | 53,213 | -6.8% | 0.03% | +13.8% |
| Q4 2016 | $583,000 | -22.5% | 57,078 | 0.0% | 0.03% | -29.3% |
| Q3 2016 | $752,000 | +100.0% | 57,078 | +93.0% | 0.04% | +70.8% |
| Q2 2016 | $376,000 | +0.3% | 29,579 | +4.2% | 0.02% | -4.0% |
| Q1 2016 | $375,000 | -14.0% | 28,379 | 0.0% | 0.02% | -13.8% |
| Q4 2015 | $436,000 | +23.9% | 28,379 | 0.0% | 0.03% | +16.0% |
| Q3 2015 | $352,000 | +0.9% | 28,379 | +11.3% | 0.02% | +8.7% |
| Q2 2015 | $349,000 | +16.3% | 25,495 | +1.7% | 0.02% | +15.0% |
| Q1 2015 | $300,000 | -6.2% | 25,061 | 0.0% | 0.02% | -9.1% |
| Q4 2014 | $320,000 | -4.8% | 25,061 | 0.0% | 0.02% | -8.3% |
| Q3 2014 | $336,000 | -13.8% | 25,061 | +3.1% | 0.02% | -14.3% |
| Q2 2014 | $390,000 | -11.0% | 24,318 | 0.0% | 0.03% | -20.0% |
| Q1 2014 | $438,000 | +12.9% | 24,318 | -3.2% | 0.04% | +12.9% |
| Q4 2013 | $388,000 | +3.7% | 25,118 | 0.0% | 0.03% | -11.4% |
| Q3 2013 | $374,000 | – | 25,118 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |